727 C (Glipizide and Metformin 2.5 mg / 250 mg)
Pill imprint 727 C has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 727 C
- Strength:
- 2.5 mg / 250 mg
- Color:
- Peach
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories,Ltd.
- National Drug Code (NDC):
- 57664-0727
- Inactive Ingredients:
- microcrystalline cellulose
povidone
croscarmellose sodium
polyethylene glycol
magnesium stearate
polyvinyl alcohol
titanium dioxide
polyethylene glycol 3350
magnesium silicate
lecithin
ferric oxide yellow
ferric oxide red
More about glipizide/metformin
Consumer resources
- Other brands: Metaglip
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
